CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. vs. Gilead Pharmasset LLC et al.

Explore the PTAB proceeding IPR2018-00103 filed by Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. on 2017-10-25. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2018-00103

Filing Date

2017-10-25

Accorded Filing Date

2017-10-25

Institution Decision Date

2018-06-13

Last Modified Date

—

Proceeding Type

IPR

Termination Date

—

Trial Status

Institution Denied

Parties & Counsel

Patent Information

1 Patent Involved
Respondent Application Number 10828753
Respondent Patent Number 7429572
Legal Expiration Date
2025-04-03 Expired (Term Ended)
Patent Term Adjustment (PTA) +347 Days Awarded
Injunction Viability (35 U.S.C. § 283) Statutorily Barred
Respondent Inventor Jeremy Clark
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Institution Denied 2018-06-13
Trial Instituted Document
35 USC 314, 37 CFR 42.100, 35 USC 325

Address and Attorney/Agent Information

47 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Venable LLP (GILEAD)
Customer Number 104538
Address 151 W. 42nd Street, 49th Floor, New York, NY, 10036, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
25512 Pasquale Razzano +1 212-218-2100
27276 Anthony Zupcic +1 212-218-2100
29296 Leonard Diana +1 212-218-2100
29836 John Murnane +1 212-218-2527
31530 Nicholas Kallas +1 212-218-2243
31865 Lawrence Perry +1 212-218-2293
32433 Scott Reed +1 212-218-2227
32533 Scott Malpede +1 202-530-1010

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2014-01-29
1:14-cv-00109

Idenix Pharmaceuticals LLC v. Gilead Pharmasset LLC

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

43
9

Notice of Refund Paper

2018-08-03 FILING PARTY: BOARD
8

Petitioner's Request for Refund of Post-Institution Fees Paper

2018-07-13 FILING PARTY: PETITIONER
7

Trial Instituted Document Paper

2018-06-13 FILING PARTY: BOARD
2007

Interference 105,981, Judgment Exhibits

2018-03-19 FILING PARTY: PATENT OWN
2014

F.D.A. Approves Pill to Treat Hepatitis C Exhibits

2018-03-19 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc